Description
The report helps businesses gain a unique insight into the socio-economic dynamics, and helps analyze how they affect healthcare systems and their evolution. It can serve as a valuable tool with actionable guidance for sales, marketing, R&D and business managers with industry related interests.
Four chapters cover the numerical and written analysis for the following topics: Economic Outlook (38 Key industry indicators), The Healthcare System (HC system structures), Reforms (restructuring, re-engineering or austerity efforts) and the Healthcare Market (Capital Equipment, Medical Devices, Disposables and Pharmaceuticals).
The TforG report is accessible through a user friendly Business Intelligence tool. Licenses are valid for 1 year.
Economic Outlook:
– Spain has a nominal GDP of €1,081 bn, equal to €23,309 per capita, with a population of 46.4m. Spain has pulled out strongly since 2013-2014 from its negative growth rate and is currently enjoying one of the higher GDP growth rates.
– Inflation in 2015 reached -0.5%, yet is expected to reach positive inflation by 2017, with 1%.
– Spain has one of the highest budget deficits in Europe, in part still recovering from bailing out Spanish banks in 2012. It has been hesitant to implement cutbacks, not wanting to halt its economic recovery.
– Overall the economic outlook is positive and promising, though structural inefficiencies remain inherent. Economic reviews must be made to ensure the sustainability of its growth, and in order to continue carrying its substantially large dependent population.
The Healthcare System:
– Healthcare authorities are highly decentralized and the organization of provisions is largely delegated to regional governments. In most regions, local healthcare departments buy additional services from the private sector in order to manage accessibility and waiting list issues.
– Healthcare spending as a percentage of GDP in 2015 was 9%, equivalent to €2,100 per capita, and €97,42 bn in total. Healthcare spending per capita decreased from 2011 (€2,170) to 2015, but is forecasted to reach above 2011 levels by 2017 (with €2,245).
– Private out-of-pocket spending has also been increasing, reaching 78% in 2015 and expected to continue rising gradually.
– In broad terms, in the Spanish healthcare financing mechanism: money follows the patient; the patient may select which provider to turn to.
– PPPs are very popular in healthcare organization; the most common type of partnership is where service contracts are granted to private hospitals by the public entity.
Healthcare Reforms:
– The main characteristics of recent healthcare reforms are:
– Cost sharing for pharmaceuticals, prostheses and ambulance services
– Reduction of salaries and staff
– No free healthcare for unregistered foreigners
– Cost cutting targets assigned to the 17 Autonomous Regions (partial privatization and outsourcing)
The Markets:
– Healthcare expenditures in Spain had to be cut by around €7 bn, i.e. 7.4%. Further budget cuts are expected.
– Spain represents the 15th largest medtech market and consumer worldwide, and one of the largest markets in the Eurozone.
– Group purchasing and non-clinical procurement experts are gaining greater decision-making authority in purchasing processes.
– Spain has one of the lowest shares in the EU of generic pharmaceuticals in its market.
– In 2015 the pharmaceutical market in Spain was valued around €17.5 bn. From the total public expenditure, pharmaceutical spending equals around 18.4%.
– The medical device market in Spain in 2015 is valued around €9 bn. It is estimated that it will grow by approximately 4% annually in the following 4 years (until 2020).
Country Overview:
Includes tables centralizing all relevant data on socio-demographics, macroeconomics and national Healthcare.
National Care Provision data:
Provides an overview of the Healthcare demographics: Nation Care provision data, Intensive Care units, Operating rooms, Emergency Rooms, Hospital services, Healthcare professionals.
© TforG Group – All Rights Reserved.
Reasons to buy
– Accurate analysis of trends, opportunities and challenges of the economy and healthcare industry
– Relevant healthcare reforms
– Written and numerical analysis on important healthcare indicators (eg. acute care data, critical care data, anesthesia data, emergency data, healthcare professionals)
– Regularly updates, at least once a year
– Every update published by TforG within 6 months after your purchase will be made available to you
– Global coverage, available for 40+ countries
– Unique insight into the socio-economic dynamics, and analysis of their effect on healthcare systems
Table of contents
Prologue
Executive Summary
Infographics
Acronyms
Chapter 1 – Economic Outlook
1.1 Socioeconomic Context
1.2 Macroeconomics
Table 1.1 – Macroeconomics (2011-2017)
1.3 Economic Outlook
Chapter 2 – The Spanish Healthcare System
2.1 Introduction
2.2 Healthcare Status
2.3 Healthcare Expenditures
Table 2.1 – Healthcare (2011-2017)
2.4 The Organization
Diagram 2.1 – Healthcare Organization (2015)
2.5 Federal Level
2.6 Regional and Local Level
2.7 Primary Care
2.8 Secondary Care
Table 2.2 – Secondary Care (2015)
2.9 Tertiary Care
2.10 Healthcare Insurance
2.11 Healthcare Financing
2.12 Financial Flows
Diagram 2.2 – Financial Flow (2015)
2.14 Private versus Public
Chapter 3 – Healthcare Reforms
3.1 Current Challenges
3.2 Recent Reforms
3.3 Hospital Operations and Priorities
Chapter 4 – The Markets
4.1 Market Profile
4.2 Purchase Processes and Decision-Making
4.3 Licensing and Regulation
4.4 Pharmaceuticals
4.5 Capital Equipment
4.6 Medical Devices
4.7 Medical Disposables
4.8 Opportunities and Market Drivers
4.9 Hospital Networks, Trade Events, GPO
Chapter 5 – Country Review
5.1 Demographics, Macroeconomics & Healthcare (2011-2017)
Chapter 6 – National Care Provision Data
6.1 Acute Care Data (2015)
6.2 Critical Care (2015)
6.3 Anesthesia (2015)
6.4 Emergency (2015)
6.5 Hospital Services Data (2015)
6.6 Healthcare Professionals (2015)
Chapter 7 – The TforG Methodology
7.1 Primary Research
7.2 Secondary Research
7.3 Our Experience
Methodology
During our 20 years of experience, TforG has been able to practice and perfect various methods of data collection, and in doing so we have evolved to combine these methods in the creation of our TforG – Direct products.
The data contained in this report was gathered using the following methods:
Primary Research
The primary research phase for TforG – Direct products makes use of two of our most prized respondent groups: The TforG Advisory Board and The TforG Hospital Network.
- Our Advisory Board (AB) boasts both clinical and non-clinical profiles (e.g. central procurement managers, payers, buyers, GPO’s and Ministry of Health members) who have broad scope of knowledge and are able to share expert opinions on future trends and country wide practices. AB members are from all over the world including the Euro-Big 5, Turkey, Russia, China, India, the U.S. and others. Yearly meetings and a series of executive interviews provide us with the necessary insights.
- Our hospital network profiles on the other hand are particularly adept at sharing “here and now” type information e.g. current clinical practices, the effects of reforms, opinions on treatments, and brand equity information. This network is contacted to share hospital level information and numerical data (i.e. prices, demographics, purchase volumes and brands). Experts in this group include clinical and non-clinical profiles (e.g. hospital administrators, CEO’s, CFO’s, COO’s, hospital strategy managers, and GPO’s).
The combination of these two points of view, allows us to provide our clients with high quality information that takes into account different situations and contexts within the medical industry.
In addition, much valuable information is generated during over 80 TforG projects conducted on a yearly basis. These projects generate hundreds of inputs across a variety of healthcare topics from respondents with both clinical and non-clinical backgrounds.
Secondary Research
Once we have completed the primary research phase, we move on to the next phase which encompasses “the confirmation” or “back-up” of the data gathered in the field.
During our secondary research phase, our dedicated team of global market analysts gather outside sources of information assembled by government agencies (i.e. MOH, social security institutions, Medical Councils, Federal pharmaceutical agencies, etc.), industry organizations, media sources, chambers of commerce, and other such sources. Published sources can include newsletters, trade publications, annual reports, magazines, and newspapers.
Our Experience
Once we have completed the first two phases of our research, our project managers will use their years of experience in projects and analysis of the facts, to put together the final package.
Request Sample Pages
Are you curious but just not ready to buy this report yet? Submit your details below to request a few sample pages.
Your enquiry will be sent to a TforG account manager and will be answered within 24 hours. You will also receive a confirmation of this by email.
National Landscape and Healthcare Outline of Spain – report 2016
This TforG report for Spain includes numerical and written analysis on the socioeconomic and macroeconomic context and outlook, the healthcare system, and the latest healthcare reforms. Moreover, an extensive chapter is dedicated to the markets for capital equipment, medical devices, disposables and pharmaceuticals.
Description
The report helps businesses gain a unique insight into the socio-economic dynamics, and helps analyze how they affect healthcare systems and their evolution. It can serve as a valuable tool with actionable guidance for sales, marketing, R&D and business managers with industry related interests.
Four chapters cover the numerical and written analysis for the following topics: Economic Outlook (38 Key industry indicators), The Healthcare System (HC system structures), Reforms (restructuring, re-engineering or austerity efforts) and the Healthcare Market (Capital Equipment, Medical Devices, Disposables and Pharmaceuticals).
The TforG report is accessible through a user friendly Business Intelligence tool. Licenses are valid for 1 year.
Economic Outlook:
– Spain has a nominal GDP of €1,081 bn, equal to €23,309 per capita, with a population of 46.4m. Spain has pulled out strongly since 2013-2014 from its negative growth rate and is currently enjoying one of the higher GDP growth rates.
– Inflation in 2015 reached -0.5%, yet is expected to reach positive inflation by 2017, with 1%.
– Spain has one of the highest budget deficits in Europe, in part still recovering from bailing out Spanish banks in 2012. It has been hesitant to implement cutbacks, not wanting to halt its economic recovery.
– Overall the economic outlook is positive and promising, though structural inefficiencies remain inherent. Economic reviews must be made to ensure the sustainability of its growth, and in order to continue carrying its substantially large dependent population.
The Healthcare System:
– Healthcare authorities are highly decentralized and the organization of provisions is largely delegated to regional governments. In most regions, local healthcare departments buy additional services from the private sector in order to manage accessibility and waiting list issues.
– Healthcare spending as a percentage of GDP in 2015 was 9%, equivalent to €2,100 per capita, and €97,42 bn in total. Healthcare spending per capita decreased from 2011 (€2,170) to 2015, but is forecasted to reach above 2011 levels by 2017 (with €2,245).
– Private out-of-pocket spending has also been increasing, reaching 78% in 2015 and expected to continue rising gradually.
– In broad terms, in the Spanish healthcare financing mechanism: money follows the patient; the patient may select which provider to turn to.
– PPPs are very popular in healthcare organization; the most common type of partnership is where service contracts are granted to private hospitals by the public entity.
Healthcare Reforms:
– The main characteristics of recent healthcare reforms are:
– Cost sharing for pharmaceuticals, prostheses and ambulance services
– Reduction of salaries and staff
– No free healthcare for unregistered foreigners
– Cost cutting targets assigned to the 17 Autonomous Regions (partial privatization and outsourcing)
The Markets:
– Healthcare expenditures in Spain had to be cut by around €7 bn, i.e. 7.4%. Further budget cuts are expected.
– Spain represents the 15th largest medtech market and consumer worldwide, and one of the largest markets in the Eurozone.
– Group purchasing and non-clinical procurement experts are gaining greater decision-making authority in purchasing processes.
– Spain has one of the lowest shares in the EU of generic pharmaceuticals in its market.
– In 2015 the pharmaceutical market in Spain was valued around €17.5 bn. From the total public expenditure, pharmaceutical spending equals around 18.4%.
– The medical device market in Spain in 2015 is valued around €9 bn. It is estimated that it will grow by approximately 4% annually in the following 4 years (until 2020).
Country Overview:
Includes tables centralizing all relevant data on socio-demographics, macroeconomics and national Healthcare.
National Care Provision data:
Provides an overview of the Healthcare demographics: Nation Care provision data, Intensive Care units, Operating rooms, Emergency Rooms, Hospital services, Healthcare professionals.
© TforG Group – All Rights Reserved.
Reasons to buy
– Accurate analysis of trends, opportunities and challenges of the economy and healthcare industry
– Relevant healthcare reforms
– Written and numerical analysis on important healthcare indicators (eg. acute care data, critical care data, anesthesia data, emergency data, healthcare professionals)
– Regularly updates, at least once a year
– Every update published by TforG within 6 months after your purchase will be made available to you
– Global coverage, available for 40+ countries
– Unique insight into the socio-economic dynamics, and analysis of their effect on healthcare systems
Table of contents
Prologue
Executive Summary
Infographics
Acronyms
Chapter 1 – Economic Outlook
1.1 Socioeconomic Context
1.2 Macroeconomics
Table 1.1 – Macroeconomics (2011-2017)
1.3 Economic Outlook
Chapter 2 – The Spanish Healthcare System
2.1 Introduction
2.2 Healthcare Status
2.3 Healthcare Expenditures
Table 2.1 – Healthcare (2011-2017)
2.4 The Organization
Diagram 2.1 – Healthcare Organization (2015)
2.5 Federal Level
2.6 Regional and Local Level
2.7 Primary Care
2.8 Secondary Care
Table 2.2 – Secondary Care (2015)
2.9 Tertiary Care
2.10 Healthcare Insurance
2.11 Healthcare Financing
2.12 Financial Flows
Diagram 2.2 – Financial Flow (2015)
2.14 Private versus Public
Chapter 3 – Healthcare Reforms
3.1 Current Challenges
3.2 Recent Reforms
3.3 Hospital Operations and Priorities
Chapter 4 – The Markets
4.1 Market Profile
4.2 Purchase Processes and Decision-Making
4.3 Licensing and Regulation
4.4 Pharmaceuticals
4.5 Capital Equipment
4.6 Medical Devices
4.7 Medical Disposables
4.8 Opportunities and Market Drivers
4.9 Hospital Networks, Trade Events, GPO
Chapter 5 – Country Review
5.1 Demographics, Macroeconomics & Healthcare (2011-2017)
Chapter 6 – National Care Provision Data
6.1 Acute Care Data (2015)
6.2 Critical Care (2015)
6.3 Anesthesia (2015)
6.4 Emergency (2015)
6.5 Hospital Services Data (2015)
6.6 Healthcare Professionals (2015)
Chapter 7 – The TforG Methodology
7.1 Primary Research
7.2 Secondary Research
7.3 Our Experience
Methodology
During our 20 years of experience, TforG has been able to practice and perfect various methods of data collection, and in doing so we have evolved to combine these methods in the creation of our TforG – Direct products.
The data contained in this report was gathered using the following methods:
Primary Research
The primary research phase for TforG – Direct products makes use of two of our most prized respondent groups: The TforG Advisory Board and The TforG Hospital Network.
The combination of these two points of view, allows us to provide our clients with high quality information that takes into account different situations and contexts within the medical industry.
In addition, much valuable information is generated during over 80 TforG projects conducted on a yearly basis. These projects generate hundreds of inputs across a variety of healthcare topics from respondents with both clinical and non-clinical backgrounds.
Secondary Research
Once we have completed the primary research phase, we move on to the next phase which encompasses “the confirmation” or “back-up” of the data gathered in the field.
During our secondary research phase, our dedicated team of global market analysts gather outside sources of information assembled by government agencies (i.e. MOH, social security institutions, Medical Councils, Federal pharmaceutical agencies, etc.), industry organizations, media sources, chambers of commerce, and other such sources. Published sources can include newsletters, trade publications, annual reports, magazines, and newspapers.
Our Experience
Once we have completed the first two phases of our research, our project managers will use their years of experience in projects and analysis of the facts, to put together the final package.
Request Sample Pages
Are you curious but just not ready to buy this report yet? Submit your details below to request a few sample pages.
Your enquiry will be sent to a TforG account manager and will be answered within 24 hours. You will also receive a confirmation of this by email.
Related products
National Landscape and Healthcare Outline of Finland – report 2016
Select optionsW-EU Surgical Procedures Volumes (all specialisms) – product license
National Landscape and Healthcare Outline (Nordics) – report
Spain Surgical Procedures Volumes (all specialisms) – product license
You may also like…
National Landscape and Healthcare Outline (EU Big 5) – report
National Landscape and Healthcare Outline (Global) – report